Ascletis Showcases Promising Data from Obesity Dru...
Category : Clinical Trial Update 5 November 2025ASC30 oral tablet achieves up to 6.5% placebo-adjusted weight reduction; injectable formulation demo...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
MetaVia Presents Positive Phase 1 and Preclinical...
Category : Clinical Trial Update 5 November 2025DA-1726 demonstrates favorable safety, dose-proportional pharmacokinetics, and meaningful weight los...
Spinogenix Reports Positive Phase 2a Results for A...
Category : Clinical Trial Update 5 November 2025SPG302 shows potential to slow disease progression and improve neuronal function in ALS patients...
Amgen to Present New Data on Repatha and Cardiovas...
Category : Clinical Trial Update 4 November 2025Amgen announced that new data from its cardiovascular portfolio, including late-breaking results fro...
ENGULF Study Demonstrates Strong Safety and Effica...
Category : Clinical Trial Update 4 November 2025Results from the pivotal cohort of the ENGULF Investigational Device Exemption (IDE) study evaluatin...
Latest Newsletter Post
-
Spinogenix Reports Positive Phase 2..
5 November 2025
-
MetaVia Presents Positive Phase 1 a..
5 November 2025
-
Ascletis Showcases Promising Data f..
5 November 2025
-
New Findings on Transdermal Curcumi..
4 November 2025
-
ENGULF Study Demonstrates Strong Sa..
4 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com